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Bidirectional non-protein-coding RNAs are ubiquitously transcribed from the genome. Convergent sense and antisense
transcripts may regulate each other. Here, we examined the convergent cis-noncoding rRNAs (nc-rRNAs) in A5 and E9 lung
cancer models. Sense nc-rRNAs extending from rDNA intergenic region to internal transcribed spacer of around 10kb in length
wereidentiﬁed.nc-rRNAsinsensedirectionexhibitedinvitrocharacteristicsofribozymes,namely,degradationuponincubation
with MgCl2 and stabilization by complementary oligonucleotides. Detection of endogenous cleavage-ligation products carrying
internal deletion of hundreds to thousands nucleotides by massively parallel sequencing conﬁrmed the catalytic properties.
Transfection of oligonucleotides pairing with antisense nc-rRNAs stabilized both target and complementary transcripts,
perturbed rRNA biogenesis, and induced massive cell death via apoptotic and/or nonapoptotic mechanisms depending on cell
type and treatment. Oligonucleotides targeting cellular sense transcripts are less responsive. Spontaneously detached cells,
though rare, also showed accumulation of nc-rRNAs and perturbation of rRNA biogenesis. Direct participation of nc-rRNAs in
apoptotic and nonapoptotic death was demonstrated by transfection of synthetic nc-rRNAs encompassing the rDNA promoter.
In sum, convergent cis-nc-rRNAs follow a feed-forward mechanism to regulate each other and rRNA biogenesis. This opens an
opportunityto disrupt rRNA biogenesis, commonly upregulated incancers, via inhibition ofribozyme-like activities innc-rRNAs.
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Noncoding RNAs are major components of mammalian
transcriptomes
1,2 and are transcribed in sense and/or
antisense directions from 60 to 70% of genomes.
3,4 Among
tens of thousands of transcription clusters examined, over
20% in humans and about 72% in mice are expressed as
sense–antisense pairs.
5–7 The levels of sense and antisense
noncoding RNA are either concordant, represented
by concurrent increase or decrease, or discordant, also
described as reciprocal regulation.
7,8 Antisense transcripts,
mostly noncoding for proteins, are known to regulate
transcriptions of many protein-coding genes in the sense
orientation, including those involved in development, immune
cell maturation, neurodegenerative diseases, and cancers.
8
Transcriptional regulation is also carried out by upstream
intergenic cis-noncoding RNAs overlapping with downstream
coding transcripts, such as for the DHFR gene in humans
9
and for the Ser3 gene in yeasts.
10 Noncoding RNAs are
detectable using common techniques, including sensitive
reverse transcription-polymerase chain reaction (RT-PCR)
and high-throughput massively parallel DNA sequencing.
However, overlapping of the cis-noncoding and primary
transcripts poses a big challenge to identify full-length
cis-RNA species for functional characterization.
Intergenic noncoding rRNA (nc-rRNA) transcripts have been
observed in rodents and humans.
11–13 A segment of the
cis-nc-rRNA has been shown to regulate transcription of the
primary rRNA in mouse ﬁbroblast cells.
14 The primary rRNA
transcript, precursor of the 18S, 5.8S, and 28S rRNAs,
undergoes serial steps of processing that begins with excision
of the leader sequence from the 50-external transcribed spacer
at about þ650 nucleotide downstream of the transcription
s t a r ts i t ei nm i c e .
15,16 Proliferating cells exhibit high levels of
ribosome production as well as increased rRNA biogenesis,
including transcription and subsequent processing, that are
orchestrated by many oncogenes and tumor-suppressor
genes.
17,18 The effects of sense–antisense nc-rRNAs on rRNA
biogenesis and cell phenotype are still unclear. In this study, we
obtained mouse strain-speciﬁc rDNA sequence and observed
that both sense and antisense nc-rRNAs were extensively
expressed in corresponding A5 and E9 mouse lung cells,
commonly used cancer models.
19 A protocol was developed
to determine full-length sequences of the sense nc-rRNAs
overlapping with the primary rRNA. Catalytic properties of
nc-rRNAs were identiﬁed. The roles of sense and antisense
cis-nc-rRNAs in rRNA biogenesis, as well as in cell growth and
death, were examined. The potential of targeting nc-rRNAs for
anticancer treatment is also discussed.
Results
Detection of extensive bidirectional cis-nc-rRNAs. More
than 14.4kbp of the rDNA covering most of the transcribed
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www.nature.com/cddisregion for primary rRNA in A5 lung cells of BALB/c mouse
background were sequenced (GenBank GU372691) using
primers selected from our assembled C57BL6 mouse
sequence (see Materials and Methods). The same primers
were used to detect sense as well as antisense nc-rRNAs
in extensive regions of the rDNA gene (Figure 1). Their
identities were conﬁrmed by dideoxy DNA sequencing. At
least three fragments of antisense nc-rRNAs were observed
and the most upstream transcription start site was located
outside the 28S region. Sense nc-rRNAs were transcribed
several hundreds to thousands of nucleotides upstream from
the primary transcription start site. The downstream regions
of the sense nc-rRNAs overlapped with the primary transcript
and determination of their 30 sequences required direct
separation of the two types of transcripts. The extensive
bidirectional cis-nc-rRNAs were also detected in the E9 lung
cell line of the same mouse background.
Identiﬁcation of long sense nc-rRNAs. A streptavidin-
coated magnetic capture-hybridization method was initially
applied to isolate sense nc-rRNAs from mouse lung cells
using only one biotin-tagged probe speciﬁc to an upstream
region of the rRNA. Initially, recovered sense nc-rRNAs were
hardly detectable using RT-PCR. Poor binding by a single
probe and RNA degradation were suspected and tested by
including two additional probes along with 30 complementary
oligonucleotides across the rDNA sequence spaced about
500 nucleotides apart. Hundred- to thousand-fold
enrichments were observed, as indicated by the increase
of the ratio of sense nc-rRNAs to the 18S rRNA and
Gapdh reference transcripts (Figure 2a). Nevertheless, the
signal for the two references remained extremely high,
suggesting nonspeciﬁc binding of these reference transcripts
to magnetic microparticles. Such undesired binding of
nontarget RNAs to excessive streptavidin epitopes was
quenched by free biotin and further 3–5-fold enrichments of
sense nc-rRNAs were achieved by addition of 0.3mM biotin in
the wash solution (Figure 2a). 10-fold higher or lower biotin
concentration attenuated the enrichment.
To determine the transcription start and end sites, the
enriched sense nc-rRNAs were circularized with T4 RNA
ligase and an intergenic primer was designed speciﬁcally to
reverse-transcribe the circular RNAs across the joined 50- and
30-termini. In all, 24 serial forward primers (Supplementary
Table S2) about 500 nucleotides apart across the rDNA
sequencewere used alongwith the samereverseprimer in an
attempt to amplify products containing the 50- and 30-termini
from circularized nc-rRNAs. Sequence alignment using
Basic Local Alignment Search Tool 2 algorithm (http://
blast.ncbi.nlm.nih.gov/Blast.cgi) identiﬁed two transcripts,
approximately 10kb in length, starting at about 300 nucleo-
tides upstream of the transcription start site and ending in
the ITS2 region (Figure 2b). The products were repeatedly
detected in separate assays using the combination of  69/
 50 reverse and þ7020 forward primers. It is noteworthy
that the two transcripts of slight length variation are also
differentiable by a single-nucleotide polymorphism at the
 104 nucleotide.
Ribozyme-like characteristics of sense nc-RNAs.
Observation of the enhanced sense nc-rRNA recovery with
the presence of 30 oligonucleotides during magnetic capture-
hybridization steps suggests that sense nc-rRNAs may carry
self-catalytic potential. To test this, total RNA was incubated
with a common ribozyme cofactor MgCl2. If sense nc-rRNAs
possess self-catalytic properties, MgCl2 would promote RNA
catalysis and complementary oligonucleotides speciﬁcally to
the transcripts would prevent the catalysis. Indeed, the signal
Antisense nc-rRNA Sense nc-rRNA
650 bp -
350 bp -
5’ 3’
-2547 +11478 +8916 -382
5.8S
Antisense nc-rRNA
3’STE ITS2 ITS1 5’ETS 5’NTS 3’NTS
-2547 -382
18S 28S
Sense nc-rRNA
Primary rRNA
+1
Figure 1 Extensive sense and antisense nc-rRNA transcripts within the rDNA locus. The gel lanes show ampliﬁed transcripts by RT-PCR and their locations in the rRNA
are identiﬁedby their 50-terminal nucleotides. Those lanes labeled with underlined nucleotide identiﬁers, also presented as dotted lines in the bottom ﬁgure, represent regions
that cannot be determined because ampliﬁcation was unsuccessful even from DNA template. NTS, nontranscribed spacer; ETS, external transcribed spacer; ITS, internal
transcribed spacer. See Supplementary Table 1 for the corresponding nucleotide locations
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Cell Death and Diseaseof sense nc-rRNAs to the reference 18S rRNA of 600bp in
size was signiﬁcantly reduced after incubation with MgCl2
and pretreatment with 30 complementary oligonucleotides
alleviated the reduction (Figure 3a). The Gapdh transcript
was not protected by the same rRNA-o rGapdh-selective
oligonucleotides (Figures 3b and c), demonstrating
noncatalytic property of mature Gapdh and the speciﬁcity
of oligonucleotide-mediated attenuation to the putative
ribozyme activity in sense nc-rRNAs. Indistinguishable
stability between the long 600-bp and the short 65-bp
(rRNA65) regions in the 18S rRNA (Figure 3d) predicts
that MgCl2 is unlikely to alter the stability of the 600-bp rRNA.
This strengthens the observation that changes of sense
nc-rRNA/18S rRNA ratios were due to RNA catalysis of
sense nc-rRNAs, not the increase of the 600-bp 18S rRNA
stability.
Identiﬁcation of catalytic sense nc-rRNAs in mouse lung
cells. Finding of the above ribozyme-like characteristics of
sense nc-rRNAs prompted us to search for endogenous
cleavage-ligation ribozyme products using the massively
parallel deep sequencing. The products were ﬁrst ampliﬁed
using a single upstream primer in combination with multiple
downstream primers (see Materials and Methods). About
22600 sequence reads of an average of 73bp in length
were collected from 26 pooled PCR products. A total of
41 sequences aligned to both upstream and downstream
regions of the BALB/c rDNA gene (GenBank GU372691) but
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Figure 2 Enrichment of sense nc-rRNAs and identiﬁcation of 50- and 30-termini of sense nc-rRNAs. (a) The ratio of RT-PCR intensity between sense nc-rRNAs and the
referencetranscript,eitherthe18SrRNAorGapdh,wasusedtocalculatethefoldenrichment(valuesinsidethehistogram)aftermagneticpuriﬁcationtreatment(T),compared
withanaliquotofuntreatedcrudeRNAbeforethepuriﬁcation(UT).Allenrichmentswerestatisticallysigniﬁcant.ThelinearscaleinY-axisrepresentstransformedvaluesusing
log (original ratio 10
7). Error bars denote ±S.E. (b) Alignment of two ampliﬁed products (bottom sequences at left and right panels) to the BALB/c rDNA sequence
(GenBank GU372691, top sequences, number in reference to transcription start site). The dotted/underlined CCG trinucleotides on the left panel cannot be assigned
unambiguously to either upstream or downstream sequences. A differential single-nucleotide polymorphism is marked by the rectangular box in these two sequences.
The T nucleotide at 277 on the right panel does not align with the rDNA sequence
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Cell Death and Diseaseshowed loss of internal portions that generated gaps of
hundreds to thousands of nucleotides (Table 1). The frequent
cleavage-ligation sites occurred between the  226 to  44
nucleotides in the upstream and two downstream hot-spot
regions, þ273 to þ556 and around þ3999 nucleotides.
It is noteworthy that these cleavage-ligation sites also
correspond to the RT-PCR region (nucleotides  241 to
þ110) showing sense nc-rRNA instability or catalysis in the
previous section.
Mutual upregulation of bidirectional nc-rRNAs and
induction of cell death. Locked nucleic acid (LNA)-DNA
gapmer oligonucleotides (Supplementary Figure S1a)
complementary to four regions around the putative catalytic
sites (Table 1) were introduced to mouse lung cells to test
if endogenous nc-rRNAs can be stabilized as seen in the
in vitro assay. Initial examination of adherent cells 24h after
LNA transfection did not detect upregulation of target nc-r
RNAs speciﬁc to any complementary LNA (Supplementary
Figure S1b). However, we noticed that LNA1-S targeting the
 103/ 85 region of antisense nc-rRNAs apparently induced
more cell detachment compared with vehicle and LNA1-AS,
a complementary strand of the LNA1-S (Figure 4a). Only
about 50% viable A5 and E9 cells remained after transfection
with LNA1-S, whereas 480% viability was seen for
the LNA1-AS, relative to vehicle treatment (Figure 4b).
This prompted us to collect detached cells from these two
treatments for RNA analysis. The cell detachment at 24h in
LNA1-AS and vehicle treatments were rare and insufﬁcient
total RNA precluded subsequent assay for nc-rRNAs despite
the effort to pool detached cells from multiple plates. For this
reason, adherent and detached cells were collected at 48h
after two LNA transfections with 24h apart. Strikingly, over
15-fold mutual upregulations of sense and antisense nc-
rRNAs were consistently detected in massively detached A5
and E9 cells induced by the LNA1-S (Figure 4c). Similar
changes were also observed in detached cells from LNA1-
AS, vehicle, and untreated samples, however, few cells
were detached and signiﬁcantly higher levels of nc-rRNAs in
LNA1-AS sample relative to LNA1-S did not translate to
more cell death. This implies that the LNA1-AS-induced
cell detachment may represent nonspeciﬁc or spontaneous
cell death as seen in vehicle and untreated samples. Taken
together, these observations strengthen the proposals
that sense and antisense nc-rRNAs follow a feed-forward
mechanism to regulate each other via suppression of
RNA catalysis and their accumulations are involved in cell
destruction. These assumptions are further supported by
small changes of nc-rRNA levels in adherent cells
(Figure 4c). Slight but signiﬁcant increases of the nc-rRNAs
in adherent cells from LNA1-S treatment compared with
either vehicle or LNA1-AS may have been a result
of upregulated transcripts from dying cells that have not yet
detached.
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Figure 3 Ribozyme-like characteristics of sense nc-rRNAs. Relative level of
sense nc-rRNAs to the 18S rRNA reference (a), of the Gapdh to the 18S rRNA (b),
and of the 18S rRNA to a 65-bp rRNA (d) in the presence/absence of rRNA-speciﬁc
complementaryoligonucleotides (rRNA
o). (c)Relativelevel of theGapdhto the18S
rRNA in the presence/absence of Gapdh-speciﬁc complementary oligonucleotides
(Gapdh
o).*Po0.05,**Po0.01,comparedwithuntreatedsampleaftertreatmentof
MgCl2, MgCl2þoligonucleotides, or oligonucleotides alone.
#Po0.05,
##Po0.01,
compared with MgCl2-treated samples. Error bars denote ±S.E.
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Cell Death and DiseaseTable 1 Cleavage-ligation products of sense nc-rRNA transcripts in mouse lung epithelial cells
Freq.
a Sequence
b 50-join
c 30-join
d Gap
e
2
1
1
1
11
2
3
1
4
5
1
1
1
1
2
1
3
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTTCTCTTCCCGGTCTTTCTTCCACATGCC
TCCCGAGTGCATTTCTTTTTTGTTTTTTTTCTTTTTTTTTGGGGGGGGAGGTGGAGAGTCCC
GAGTACTTCACTCCTGTCTGCGGTGTCCAAGTGTTCATGCCACGTGCCTCCCGAGTGCACTT
TTTTTTTGTGGCAGTCGCTCGTTGTGTTCTCTTGTTCTGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTTCTTTCATTGACCTGTCGCTCTTTTCTCTTCC
CGGTCTTTCTTCCACATGCCTCCCGAGTGCATTTCTTTTTGTTTTTTTTCTTTTTTTTTGGG
GGGGGAGGTGGAGAGTCCCGAGTACTTCACTCCTGTCTGCGGTGTCCAAGTGTTCATGCCAC
GTGCCTCCCGAGTGCACTTTTTTTTTGTGGCAGTCGCTCGTTGTGTTCTCTTGTTCTGTGTC
TGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGGTCTTATCAGTTCTC
CCGGTTGGAATGGTGGAGCCAGCTGTGGTTGAGGGCCGCCTTATTTCGGCTCAC...
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGGTCTTATCAGTTCTC
CCGGTTGTCAGGTCGACCAGTTGTTCCTTTGAGGTCCGGTTCTTTTCGTTATGGGGTCATTT
TTGGGCCACCTCCCCAGGTATGACTTCCAGGTATTCTTTGTGGCAGTCGCTCGTTGTGTTCT
CTTGTTCTGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGGTCTTATCAGTTCTC
CCGGTTGTGGCAGTCGCTCGTTGTGTTCTCTTGTTCTGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTGGCCCAGGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGGTCTTATCAGTTCTC
TTGTTCTGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGGTCTTATCAGTTCTC
CTGTTCTGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGGTCTTATCAGTTCTC
CTGTCTGCGGTGTCCAAGTGTTCATGCCACGTGCCTCCCGAGTGCACTTTTTTTTGTGGCAG
TCGCTCGTTGTGTTCTCTTGTTCTGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGGTCTTATCAGTTCTC
CCGGTTGTCAAGTCGACCAGTTGTTCCTTTGAGGTCCGGTTCTCTTGTTCTGTGTCTGCCCG
TATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGGTCTTATCAGTTCTC
CCGGTTGTGTTCTCTTGTTCTGTGTCTGCCCGTATC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGGTCTTATCAGTTCTC
CC CGTTGTGTTCTCTTGTTCTGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTCTCTTGTTCTGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTGTTCTGTGTCTGCCCGTATCAGTAAC
GAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGCTCGTTGTGTTCTCTTGTTC
TGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTATGGGCGCGGTTTTCTTTCATTGACCTGTCGGTCTTATCAGTTCTC
CGGGTTGTCAGGTCGACCAGTTGTTCCTTTGAGGTCCGGTTCTTTTCGTTATGGGGTCATTT
TTGGGCCACCTCCCCAGGTATGACTTCCAGGTATTCTCTGTGGCCTGTCACTTTCCTCCCTG
TCTCTTTTATGCTTGTGTTCTCTTGTTCTGTGTCTGCCCGTATCAGTAAC
AGGCCGAGGGAAAGCTACCTGGTTGATCCTGCCAGTAGCATATGCTTGTCTCAAAGATTAAG
CCATGCATGTCTAAGTACGCACGGC
–213
–197
–182
–77
–176
–210
–186
–179
–183
–142
–177
–178
–217
–209
–199
–44
–226
+366
+360
+273
+523
+527
+556
+549
+550
+471
+548
+543
+537
+546
+551
+535
+544
+3999
574
555
446
599
699
766
729
729
650
685
715
715
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583
4223
aThe frequency of occurrence.
bSolid lines: primer sequences; dotted lines: cleavage-ligation regions but difﬁculty in assigning to a speciﬁc nucleotide; boxed
sequence: does not match to either 50 or 30 sequences.
cThe nucleotide immediately adjacent to the 50-end of sequences with dotted lines.
dThe nucleotide
immediately adjacent to the 30-end of sequences with dotted lines.
eThe number of nucleotides in the internal region were deleted
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Cell Death and DiseaseBecause nc-rRNAs are overlapping and/or complementary
to primary rRNA, their mutual upregulations may potentially
alter rRNA biogenesis. Indeed, all detached cells were
frequentlydetected withaccumulation of pre-rRNAs,revealed
by the leader- or 50 ETS-containing transcripts corresponding
to the 47S and/or 45S rRNAs during rRNA biogenesis
(Figure 4c). The detached cells from LNA1-S treatment
elevated both 47S and 45S rRNAs, whereas others showed
accumulation at the 45S rRNA step. The LNA1-S appears to
perturbrRNAbiogenesisviaamechanismdistinctfromLNA1-
AS and spontaneous cell detachment.
Cell death via apoptotic and nonapoptotic mechanisms.
It is known that disruption of rRNA biogenesis triggers
apoptosis.
20 To test this hypothesis in LNA-treated cells,
internucleosomal DNA breaks, indicative of apoptosis, as well
as cell cycle were examined. The LNA1-S indeed enhanced
apoptosis in A5 at 24h, revealed by a steam-like appearance
of cell population with intense labeling of internucleosomal
DNA breaks in the scatter plot (Figure 5a, upper left and upper
right fractions). Growth in A5 was also suppressed,
represented by reduction in the S-phase fraction of cell cycle
(Figure 5b). The apoptotic cell death and growth suppression
in A5 were clearly more prominent in the LNA1-S treatment
than the LNA1-AS, excluding possible effects simply due to the
presence of oligonucleotides and delineating the mechanism
of cell inhibition upon stabilization of antisense nc-rRNAs. In
contrast, the apoptotic response in E9 at 24h was insigniﬁcant
(Figure 5a) and much lower than the estimated 50% reduction
of cell viability (Figure 4b), providing evidence that LNA1-S
also mediates death via mechanisms other than apoptosis.
Neither LNA1-S nor LNA1-AS exerted any effect on cell cycle
in E9 (Figure 5b).
To further demonstrate that antisense nc-rRNAs are
potential targets for induction of apoptosis, additional com-
plementary LNAs listed in Supplementary Figure S1a were
tested.AsshowninFigure6a,LNA4-S,complementarytothe
þ484/þ502 region of antisense nc-rRNAs, was more potent
than other LNAs targeting sense nc-rRNAs to induce
the steam-like appearance of apoptotic cell population in the
scatter plot of A5 cells. The apoptotic responses of E9 cells to
these LNAs including LNA4-S were small at 24h (Figure 6a),
similar to the LNA1-S treatment (Figure 5a). The 48-h
treatment of LNA1-S and LNA4-S was required to trigger
extensive apoptosis in E9 (Figure 6b). The LNA4-S remained
highly apoptogenic in A5 at 48h. In contrast, the 48-h
incubation with LNA1-S reduced apoptotic fractions in A5
compared with 24-h treatment in Figure 5a, suggesting that
cell death switches from apoptotic to nonapoptotic mechan-
ism after prolonged LNA1-S treatment. Similar striking
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Figure 4 Thelevels of nc-rRNAs,pre-rRNAs, and cell viability after LNA1-Sand LNA1-AStreatments.(a) Abundant dead cells, represented by the dense granules under
microscope, were immediately recognizable in cells 24h after transfection with LNA1-S ( 50 magniﬁcation). (b) The viable cells relative to vehicle treatment were also
signiﬁcantly reduced at 24h after LNA treatments and the effect was more pronounced for LNA1-S, compared with LNA1-AS (*Po0.05; **Po0.0005). Error bars denote
±S.E. (c) Heat map for the nc-rRNA and pre-rRNA proﬁles in A5 and E9 cells at 48h following two transfections of LNA gapmer with 24h apart. Statistically signiﬁcant
changesinreferencetocorrespondingtranscriptsinvehicle-treatedadherentcellswerecoloredinredforupregulationandingreenfordownregulation.Numbersindicatefold-
changes and P-values. *Po0.05 for transcript differences between LNA1-S and LNA1-AS treatment in adherent and detached cells
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Cell Death and Diseasecell-killingefﬁcacybetweenLNA4-SandLNA1-Spromptedus
to examine whether LNA4-S induces stabilizations of
bidirectional nc-rRNAs as seen for the LNA1-S. Detached
cells from the LNA4-S treatment in fact carried extremely
high levels of sense and antisense nc-rRNAs, as well as
pre-rRNAs, whereas only small changes were observed in
adherent cells (Figure 6c), conﬁrming the same feed-forward
mechanism utilized by LNA4-S and LNA1-S.
Concomitant upregulation of bidirectional nc-rRNAs and
cell death after LNA1-S and LNA4-S treatments raised the
possibility that nc-rRNAs may function as death mediators.
To test this hypothesis, in-vitro synthesized nc-rRNAs in
sense and antisense orientations (Figure 7) were transfected
into A5 and E9 cells. Initial trials of 0.5–4nM nc-rRNAs did not
appear to be cytotoxic in both cell lines 48h after transfection.
Differential apoptotic and nonapoptotic death responses were
detected following nearly 48-h treatments with 8nM 1S, 2S,
1AS, and/or 2AS nc-rRNAs (Figure 7). These nc-rRNAs
signiﬁcantly increased apoptotic and nonapoptotic cell killing
compared with NS nc-rRNA, which was not originally present
in mouse lung cells (Figure 1), strengthening the role of
endogenous nc-rRNAs in regulation of the multiple death
pathways.
Discussion
Screening of noncoding transcripts within the rDNA loci has
identiﬁed extensive bidirectional cis-nc-rRNAs. The extent of
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Figure 5 Effects on apoptosis and cell cycle at 24h after single transfection of LNAs. (a) The upper left (UL) and upper right (UR) fractions represent estimated apoptotic
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intensity; Y-axis: ﬂuorescein intensity in log scale). (b) Histogram of cell cycle shows G0/G1, S, and G2/M phases (X-axis: propidium iodide intensity; Y-axis: cell count).
The large sub-G0/G1 population in LNA1-S-treated A5 cells is consistent with the marked increase of apoptotic cells in (a).
#Po0.05, compared with vehicle; *Po0.05,
compared with LNA1-AS
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Cell Death and Diseaseantisense nc-rRNAs is consistent with a recent report.
21 This
raises a possibility that the rRNA biogenesis, a key process to
sustain cell growth and survival,
17,18 is regulatedby nc-rRNAs
at multiple sites. Both sense and antisense nc-rRNAs are
discontinuous, suggesting that transcription of these multiple
nc-rRNAs may be initiated independently, though posttran-
scriptional RNA processing cannot be excluded. Sense
nc-rRNAs, transcribed from regions upstream to the rRNA
transcription start site, have been described before
12,13 and
thought to be initiated from a spacer promoter at  2026 to
 1996 region in mice (GenBank BK000964). Several
termination sites have been also reported, including  170
and  182 nucleotides.
12,13 In this study, we detected a sense
transcript covering the  2547 region and two long sense
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Cell Death and Diseasenc-rRNAs encompassing regions of  321 to þ7295 and
 238 to þ7246. Transcription of sense nc-rRNA across the
primary rRNA start site is conserved in humans,
11 supporting
the idea that nc-rRNAs are biologically important in mamma-
lian cells. Also, application of multiple capture probes and
complementary oligonucleotides across gene locus is essen-
tial to prevent catalysis of nc-rRNAs.
Self-catalytic R2 retrotransposons in the 28S rRNA region
have been described recently.
22 The rRNA component of the
ribosome is known to catalyze translation via its peptidyl
transferase activity.
23,24 Observation of the ribozyme-like
properties in nc-rRNAs is very intriguing and supports that
rRNAs and nc-rRNAs are highly reactive with diverse
biological functions. Also, these nc-rRNAs and perhaps
noncoding RNAs in other genes may require self-catalytic
RNA processing before carrying out their putative functions.
Suppression of ribozyme activity may consequently lead
to unfavored phenotype, such as cell death.
As predicted, introduction of complementary LNAs
stabilizes sense and antisense nc-rRNAs in mouse lung cells
and induces cell death. Mutual upregulation of the bidirec-
tional nc-rRNAs is consistent with inhibition of ribozyme-like
activity by complementary sequences, LNA1-S/antisense nc-
rRNAs, LNA4-S/antisense nc-rRNAs, and antisense/sense
nc-rRNAs pairs. The ribozyme-like properties of the sense
nc-rRNAs have been demonstrated in the in-vitro
assay. Stabilization of antisense nc-rRNAs after LNA1-S
and LNA4-S treatments provides the evidence that antisense
transcripts also carry ribozyme-like properties. The bidirec-
tional nc-rRNAs apparently act through a feed-forward
mechanism upon LNA treatment to regulate each other
and to induce cell death. Viable cells retain basal levels of
nc-rRNAs. Similar feed-forward mechanisms between sense
and antisense transcripts have been described before,
25,26
but it is not clear whether any ribozyme activity is involved
in those genes.
Several sense and antisense nc-rRNAs are known to
regulaterRNAbiogenesis.Ectopicexpressionofanintergenic
sense nc-rRNA from  142 to  40 nucleotides has been
shown to displace nucleolar remodeling complex and
to upregulate the 47S rRNA in mouse ﬁbroblast cells.
14
Suppression of rRNA transcription but accumulation of the
45S rRNA by sense and antisense nc-rRNAs from the 50 ETS
region have been reported in human cancer cells.
27 In the
current study, we demonstrate that upregulation of endogen-
ous nc-rRNAs can be achieved by introduction of antisense
oligonucleotides, a useful tool for future in vivo experiments.
Strikingly, stabilization of endogenous nc-rRNAs induces
cell death as well as upregulations of 47S and/or 45S rRNAs.
The role of nc-rRNA stabilization in cell death is further
supported by concurrent accumulations of pre-rRNA levels
and nc-rRNAs in spontaneously detached cells from vehicle
and untreated controls (Figure 4c). LNA1-S and LNA4-S are
not complementary to pre-rRNAs, and therefore, the pertur-
bation of rRNA biogenesis is likely mediated by direct
interaction with antisense nc-rRNAs. The two distinct pre-
rRNA proﬁles in LNA1-S and LNA4-S treatments versus
LNA1-AS and controls suggest that different sets of antisense
nc-rRNAs may be involved in regulation of rRNA biogenesis.
Taken together, these observations strengthen the proposal
that antisense nc-rRNAs, upregulated by a feed-forward
mechanism involving ribozyme inhibition, serve as death
mediators by exerting interferences at different steps of rRNA
biogenesis.
Activation of the cell-death pathway via stabilizations of
both sense and antisense nc-rRNAs may represent a novel
anticancer strategy. The death mechanism varies depending
on cell type and treatment schedule. Apoptotic response is
readily detectable in A5 with a single LNA dosing, whereas E9
requires multiple treatments. Mechanisms other than apop-
tosis dominate the LNA-induced cell death in E9, supporting
that nc-rRNAs mediate cell destruction through multiple
pathways. This is further conﬁrmed by detection of apoptotic
and nonapoptotic death in A5 and E9 cells following
transfection of synthetic nc-rRNAs (Figure 7), consistent with
a recent report using human cells.
28 The preferential killing of
LNAs complementary to antisense nc-rRNAs, compared
with those pairing with sense nc-rRNAs, may be explained
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Figure 7 Direct induction of cytotoxicity and apoptosis by in vitro-synthesized
nc-rRNAs. Cytotoxicity and apoptosis relative to viability was illustrated for cells
(A5 and E9) 45h after single transfection of selected nc-rRNA transcripts (sense:
1S and 2S; antisense: 1AS and 2AS, see upper panel for their locations).
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±S.E. from triplicate samples. Error bars denote ±S.E.
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Cell Death and Diseaseby better accessibility of antisense nc-rRNAs than their sense
counterparts to complementary oligonucleotides, however,
this remains to be tested. Many anticancer drugs have been
shown to promote cell death by disrupting different stages of
the rRNA biogenesis in various cancer types.
29–31 Among
them, 50-ﬂuorouracil is known to carry a property to inhibit
ribozymatic self-cleavage in mammalian cells.
32 Identiﬁcation
of ribozyme-like properties in nc-rRNAs represents a new
opportunity to screen small molecules for cancer-selected
treatment. In conclusion, the current ﬁndings of ribozyme-
like nc-rRNAs and their functions to mediate cell death,
via apoptotic and non-apoptotic pathways, and/or growth
suppression provide proof of principle that nc-rRNAs are
promisingtargetsforthe discoveryofpotent anticancerdrugs.
Materials and Methods
Cell lines. Spontaneously transformed E9 and A5 lung-cancer cell lines
of BALB/c mouse origin were obtained from Dr. A Malkinson, the University of
Colorado, and Dr. S Jakowlew, the National Cancer Institute, respectively. E9 cells
were cultured in CMRL 1066 medium and A5 cells were maintained in Dulbecco’s
modiﬁed Eagle’s medium (Invitrogen, Carlsbad, CA, USA), supplemented with
4mM glutamine, 100mg/ml penicillin/streptomycin, and 10% fetal calf serum. Cells
in T-150 ﬂasks were grown in a 371C incubator (Thermo Scientiﬁc, Waltham, MA,
USA)provided with 7%carbon dioxideair.Near-conﬂuentcellswereharvestedwith
0.05% trypsin-EDTA and then washed with phosphate-buffered saline before
storage at  701C.
Compilation of a mouse strain-speciﬁc rDNA sequence. We
previously sequenced a 625-bp upstream region of the rDNA from BALB/c mice
(unpublished) and observed 499% homology to a C57BL/6J sequence (GenBank
NW_040290).Tominimizemispairingofprimersduetosequencevariationbetween
mouse strains, a full-length rDNA of C57BL/6J was compiled from two contigs
(GenBank AC170254 and AF441733) by aligning with the assembled rDNA
(GenBank BK000964) of the Swiss mouse strain. Primers were designed using
Oligo 6 software (Molecular Biology Insights, Cascade, CO, USA) and the compiled
C57BL/6 rDNA-homologous sequence.
RNA extraction and puriﬁcation. Total RNA from A5 and E9 cells was
extracted using the RNeasy kit (Qiagen, Germantown, MD, USA) and processed
according to the manufacturer’s protocol with a modiﬁcation to extend the elution of
RNA to 30min. The eluted RNA was subsequently treated with DNase to remove
residual DNA, as described in the directions of the DNA-Free kit (Applied
Biosystems, Foster City, CA, USA) and puriﬁed using Microcon 50 spin columns
(Millipore, Bedford, MA, USA). RNA quantiﬁcation was carried out using a
spectrophotometer (Hewlett Packard, Mississauga, Ontario, Canada).
RT-PCR. The Superscript III enzyme was used to carry outRT at 501C following
the manufacturer’s protocol (Invitrogen). Quantitative PCR was performed in the
Chromo4 System (MJ Research, Waltham, MA, USA). PCR was carried out in a
series of steps initiated by a 15-min incubation at 951C. Subsequent three-step
reactionswererepeatedforatotalof50times,consistingof941Cfor10s,551Cfor
30s, and 721C for 90s. Each PCR reaction contained 2ml cDNA, 0.5mM primers,
and1xSYBRGreenPCRMIX(Qiagen)in20ml ofsolution.Samplesfromreactions
omitting reverse transcriptase were used to verify that the reaction did not amplify
residual DNA. Primers used for screening putative sense and antisense nc-rRNAs
were chosen with similar computed melting temperatures (Supplementary Table
S1). The probes and RT-PCR primers for the sense nc-rRNA enrichment analysis,
sequence determination of the 50- and 30-termini of the enriched sense nc-rRNAs,
and test of ribozyme activitiesare listed in Supplementary Table S2. The transcripts
of sense and antisense nc-rRNAs and pre-rRNAs containing the leader sequence
and other 50 ETS region were also quantiﬁed using real-time PCR after RT.
RT primerswere:50-GAGACAAACCTGGAACG-30 (for thetwopre-rRNAs), 50-ACC
TATCTCCAGGTCCAATAGG-30 (for sense nc-rRNAs), and poly-T20 (for antisense
nc-rRNAs).The correspondingPCR primers for each region were 50-GTGGAGAGT
CCCGAGTACTT-30/50-GGGGCAAGACAGTTACTGATA-30 (leader sequence),
50-ACGTGTTTCACTTTGGTCGT-30/50-ACCTCGACGCTTACAAGAAA-30 (50 ETS),
50-GCGGTTTTCTTTCATTGACC-30/50-ACCTATCTCCAGGTCCAATAGG-30 (sense
nc-rRNAs), and 50-GCGGTTTTCTTTCATTGACC-30/50-CCTTAAATCGAAAGGGT
CTCTT-30 (antisense nc-rRNAs). The Gapdh was used as an internal control.
Enrichment of putative sense nc-rRNAs. A magnetic capture-
hybridization protocol, based on the hybridization of a biotinylated probe to the
target transcript and capture of the hybrid with streptavidin-coated magnetic beads,
was developed to enrich putative sense nc-rRNAs. The magnetic sphere and stand
were purchased from Promega (PolyATtract Isolation System III, Madison, WI,
USA), and several conditions were tested to maximize the isolation of sense nc-
rRNAs. Biotinylated probes (Supplementary Table S2) were designed to bind
speciﬁcally to the 50 regions of sense nc-rRNAs that are not present in the primary
rRNA transcript. For the ﬁrst condition, 100mg total RNAs were heat-denatured at
651C for 5min in the presence of probes only. The second condition included 30
oligonucleotides (Supplementary Table S1) in the heat denaturation step. The third
conditionwasthesameasthesecond,exceptinclusionofvariousconcentrationsof
biotininthe0.1  sodiumchloride/sodiumcitratewashbuffer(15mMNaCl,1.7mM
Na3 citrate, pH 7.2). Duplicated RT and PCR were performed independently.
The level of enrichment was expressed as a ratio to the 18S rRNA and to Gapdh
internal controls.
Determination of 50- and 30-termini of sense nc-rRNAs. The sense
nc-rRNAs enriched by the magnetic capture hybridization were phosphorylated
at the 50-end using T4 polynucleotide kinase and subsequently circularized by T4
RNA ligase 1 (New England BioLabs, Ipswich, MA, USA). Phosphorylation and
circularization were carried out in a 50-ml reaction mixture containing the same
buffer (50mM Tris-HCl, 10mM MgCl2, 1mM ATP, and 10mM dithiothreitol, pH 7.8)
and an aliquot of the bead-enriched RNAs. The reaction was ﬁrst incubated with
10U of T4 kinase for 30min at 371C, followedby theaddition of 20U of T4 ligase 1
and overnight incubation at 161C. Regions of the joint 50- and 30-termini of
circularized sense nc-rRNAs were PCR-ampliﬁed and determined by dideoxy DNA
sequencing.
Test of ribozyme activities of nc-rRNAs. An aliquot of 3mg total RNA in
100ml diethyl pyrocarbonate (DEPC) water was processed through serial steps of
heating at 651C for 5min, cooling on ice for 5min, incubating for 1h in a solution
at 41C, and puriﬁcation by Microcon 30 before RT-PCR. For ribozyme
characterization, 30 rRNA-o r6Gapdh-speciﬁc complementary oligonucleotides
(Supplementary Tables S1 and S2) were added before the 65-1C heating step.
DEPC water or 10mM MgCl2 was introduced at the 1-h 41C incubation step.
Amplicon deep sequencing. Initial PCRs were carried out using cDNAs,
generated with RT primers (Supplementary Table S1) and total RNAs from A5 cells,
and the same forward concatenated primer in combination with 26 reverse
primers (Supplementary Table S3). Products of the 26 PCRs were resolved in DNA
Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA) and quantiﬁed. The
concentrations of the 26 PCR products were adjusted before pooling to have equal
representation of individual products. The 454 GS FLX instrument and Titanium
amplicon sequencing kit were used, as described in the manufacturer’s protocol
(Roche, Indianapolis, IN, USA). DNA sequencing was performed at  500 coverage.
Gel electrophoresis and dideoxy DNA sequencing. PCR products
were separated on a 10% polyacrylamide gel (Invitrogen), stained with 0.5mg/ml of
ethidium bromide, and visualized using an Epi Chem II Darkroom Imaging System
(UVP, Upland, CA, USA). Product sizes were estimated in reference to a 50-bp
molecular weight marker. For DNA sequencing, PCR products were puriﬁed using
the GFX puriﬁcation columns (General Electric, Cleveland, OH, USA) and
sequences were determined by conventional Sanger’s dideoxy method.
Transfection. A5 and E9 cells at about 40–60% density in six-well plates were
transfected with 50nM LNA-DNA gapmer (Sigma-Aldrich, St. Louis, MO, USA)
using the RNAiFect transfection kit (Qiagen) according to the manufacturer’s
instruction. LNA1-AS (TACCtggaagtcataCCTG, upper cases denote LNAs), LNA1-
AS1 (TACCTggaagtcatACCTG), LNA2-AS (TAACActaaaggacACTAG), LNA2-AS1
(TAACActaaaggacACTAT), and LNA3-AS (AAAaagatccaaagctCCA) are comple-
mentary to sense nc-rRNAs, whereas LNA1-S (CAGGtatgacttccaGGTA), LNA2-S
(TAAcactaaaggacacTAT),LNA2-S1(TAAcactaaaggacacTAG),LNA3-S(TGGagcttt
ggatcttTTT), and LNA4-S (TGTCCaagtgttcaTGCCA) are pairing with antisense
nc-rRNAs. Cell images were taken utilizing a Zeiss Imaging System (Carl Zeiss
Cis-noncoding rRNA-mediated cell death
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Cell Death and DiseaseMicroImaging, Inc., Thornwood, NY, USA). In-vitro synthesized nc-rRNAs (8nM),
transcribed from PCR templates and puriﬁed as previously described,
28 were
transfected into cells cultured in a 96-well plate using TransIT-mRNA Transfection
kit (Mirus, Madison, WI, USA) according to the manufacturer’s protocol.
Cellviability,apoptosis,andcell-cycleanalyses. CellTiter96AQone
solution cell proliferation kit (Promega) converting a tetrazolium compound to
formazan for cell-viability measurement and Apo-BrdU (Phoenix Flow Systems,
San Diego, CA, USA) for apoptosis as well as cell-cycle analyses were carried out
according to manufacturer’s instructions. Cells were cultured in a 96-well plate for
CellTiter and in T-25 ﬂasks for Apo-BrdU assays. Assessment of cell viability,
cytotoxicity, and apoptosis from the same cell sample in 96-well plate was carried
out using ApoTox-Glo Triplex Assay kit (Promega) following the manufacturer’s
direction. More than 10000 cells were collected after the Apo-BrdU staining
using a Flow Cytometer. WinMDI 2.8 (http://www.cyto.purdue.edu/ﬂowcyt/software/
Winmdi.htm) and Cylchred (http://www.facslab.toxikologie.uni-mainz.de/engl.%20
Websites/Downloads-engl.jsp) software were used to calculate the fraction of
apoptotic cells and three phases of cell cycle, respectively.
Statistical analysis. Nonparametric Mann–Whitney test was applied to
compare treated and untreated samples in sense nc-rRNA enrichment experiment
and ribozyme-like characterization experiments. For ribozyme-like characterization
and changes of nc-rRNAs, pre-rRNAs, and cell populations (viability, cytotoxicity,
apoptosis, and/or cell cycle) after LNA or synthetic nc-rRNAs treatments, unpaired
Student’s t-test was used. The differences between comparisons were considered
signiﬁcant if P-values were o0.05.
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